[Skip to Content]
[Skip to Content Landing]
Commentary
October 2006

Comparative Effectiveness of Antipsychotic DrugsA Commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

Arch Gen Psychiatry. 2006;63(10):1069-1072. doi:10.1001/archpsyc.63.10.1069

Despite schizophrenia's longstanding affliction of humankind,1 effective treatments for this debilitating disorder only became available in the middle of the 20th century.2 Numerous, now landmark, studies35 demonstrated incontrovertibly that chlorpromazine, the prototypic antipsychotic, was more effective than nonpharmacologic treatment (eg, placebo, psychotherapy) in alleviating the acute symptoms of schizophrenia and preventing their recurrence. Although many effective antipsychotics have been introduced in the wake of chlorpromazine, the pace of real progress through drug development and innovation has been arduous and slow.

First Page Preview View Large
First page PDF preview
First page PDF preview
×